These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8797479)

  • 1. ApoE and CYP2D6 polymorphism with and without parkinsonism-dementia complex in the people of Chamorro, guam.
    Chen X; Xia Y; Gresham LS; Molgaard CA; Thomas RG; Galasko D; Wiederholt WC; Saitoh T
    Neurology; 1996 Sep; 47(3):779-84. PubMed ID: 8797479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP2D6 is associated with Parkinson's disease but not with dementia with Lewy Bodies or Alzheimer's disease.
    Atkinson A; Singleton AB; Steward A; Ince PG; Perry RH; McKeith IG; Fairbairn AF; Edwardson JA; Daly AK; Morris CM
    Pharmacogenetics; 1999 Feb; 9(1):31-5. PubMed ID: 10208640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein E in Guamanian amyotrophic lateral sclerosis/parkinsonism-dementia complex: genotype analysis and relationships to neuropathological changes.
    Buée L; Pérez-Tur J; Leveugle B; Buée-Scherrer V; Mufson EJ; Loerzel AJ; Chartier-Harlin MC; Perl DP; Delacourte A; Hof PR
    Acta Neuropathol; 1996; 91(3):247-53. PubMed ID: 8834536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYP2D6 gene polymorphism as a probable risk factor for Alzheimer's disease and Parkinson's disease with dementia.
    Gołab-Janowska M; Honczarenko K; Gawrońska-Szklarz B; Potemkowski A
    Neurol Neurochir Pol; 2007; 41(2):113-21. PubMed ID: 17530572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurogenetic correlates of Parkinson's disease: apolipoprotein-E and cytochrome P450 2D6 genetic polymorphism.
    Bon MA; Jansen Steur EN; de Vos RA; Vermes I
    Neurosci Lett; 1999 May; 266(2):149-51. PubMed ID: 10353349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TAU as a susceptibility gene for amyotropic lateral sclerosis-parkinsonism dementia complex of Guam.
    Poorkaj P; Tsuang D; Wijsman E; Steinbart E; Garruto RM; Craig UK; Chapman NH; Anderson L; Bird TD; Plato CC; Perl DP; Weiderholt W; Galasko D; Schellenberg GD
    Arch Neurol; 2001 Nov; 58(11):1871-8. PubMed ID: 11708997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of phosphorylation sites in PHF-TAU from patients with Guam amyotrophic lateral sclerosis/parkinsonism-dementia complex.
    Mawal-Dewan M; Schmidt ML; Balin B; Perl DP; Lee VM; Trojanowski JQ
    J Neuropathol Exp Neurol; 1996 Oct; 55(10):1051-9. PubMed ID: 8858002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of tau pathologies in gray and white matter of Guam parkinsonism-dementia complex.
    Winton MJ; Joyce S; Zhukareva V; Practico D; Perl DP; Galasko D; Craig U; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2006 May; 111(5):401-12. PubMed ID: 16609851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occurrence of alpha-synuclein pathology in the cerebellum of Guamanian patients with parkinsonism-dementia complex.
    Sebeo J; Hof PR; Perl DP
    Acta Neuropathol; 2004 Jun; 107(6):497-503. PubMed ID: 15024581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurodegenerative diseases of Guam: analysis of TAU.
    Pérez-Tur J; Buée L; Morris HR; Waring SC; Onstead L; Wavrant-De Vrièze F; Crook R; Buée-Scherrer V; Hof PR; Petersen RC; McGeer PL; Delacourte A; Hutton M; Siddique T; Ahlskog JE; Hardy J; Steele JC
    Neurology; 1999 Jul; 53(2):411-3. PubMed ID: 10430438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Polymorphisms in the genes of cytochrome oxidase P450 2D6 (CYP2D6), paraoxonase 1 (PON1) and apolipoprotein E (APOE) as risk factors for Parkinson's disease].
    Durić G; Svetel M; Nikolaevic SI; Dragadević N; Gavrilović J; Kostić VS
    Vojnosanit Pregl; 2007 Jan; 64(1):25-30. PubMed ID: 17304721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lessons from Guam ALS/PDC study].
    Asao H
    Rinsho Shinkeigaku; 2007 Nov; 47(11):717-21. PubMed ID: 18210783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial nature and continuing morbidity of the amyotrophic lateral sclerosis-parkinsonism dementia complex of Guam.
    McGeer PL; Schwab C; McGeer EG; Haddock RL; Steele JC
    Neurology; 1997 Aug; 49(2):400-9. PubMed ID: 9270568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case-control study of debrisoquine 4-hydroxylase, N-acetyltransferase 2, and apolipoprotein E gene polymorphisms in Parkinson's disease.
    Maraganore DM; Farrer MJ; Hardy JA; McDonnell SK; Schaid DJ; Rocca WA
    Mov Disord; 2000 Jul; 15(4):714-9. PubMed ID: 10928584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E allele in Chamorros with amyotrophic lateral sclerosis/parkinsonism-dementia complex.
    Waring SC; O'Brien PC; Kurland LT; Thibodeau SN; Tsai MS; Petersen RC; Esteban-Santillan CE
    Lancet; 1994 Mar; 343(8897):611. PubMed ID: 7906373
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevalence of dementia in Chamorros on Guam: relationship to age, gender, education, and APOE.
    Galasko D; Salmon D; Gamst A; Olichney J; Thal LJ; Silbert L; Kaye J; Brooks P; Adonay R; Craig UK; Schellenberg G; Borenstein AR
    Neurology; 2007 May; 68(21):1772-81. PubMed ID: 17515539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The apolipoprotein epsilon 4 allele in Parkinson's disease with and without dementia.
    Marder K; Maestre G; Cote L; Mejia H; Alfaro B; Halim A; Tang M; Tycko B; Mayeux R
    Neurology; 1994 Jul; 44(7):1330-1. PubMed ID: 8035940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Cu/Zn superoxide dismutase gene in ALS and parkinsonism-dementia of Guam.
    Figlewicz DA; Garruto RM; Krizus A; Yanagihara R; Rouleau GA
    Neuroreport; 1994 Jan; 5(5):557-60. PubMed ID: 8025243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hippocampal sclerosis in the parkinsonism-dementia complex of Guam: quantitative examination of neurons, neurofibrillary tangles, and TDP-43 immunoreactivity in CA1.
    Oyanagi K; Yamazaki M; Hashimoto T; Asakawa M; Wakabayashi K; Takahashi H
    Neuropathology; 2015 Jun; 35(3):224-35. PubMed ID: 25783521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of association of APOE and tau polymorphisms with dementia in Parkinson's disease.
    Ezquerra M; Campdelacreu J; Gaig C; Compta Y; Muñoz E; Martí MJ; Valldeoriola F; Tolosa E
    Neurosci Lett; 2008 Dec; 448(1):20-3. PubMed ID: 18930114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.